These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9633000)

  • 21. Acyclovir: the next new HIV drug?
    Proj Inf Perspect; 2009 Mar; (48):8-9. PubMed ID: 19492460
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV-1 dynamics in vivo: implications for therapy.
    Simon V; Ho DD
    Nat Rev Microbiol; 2003 Dec; 1(3):181-90. PubMed ID: 15035022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-emergence of HIV after stopping therapy.
    Chun TW; Davey RT; Engel D; Lane HC; Fauci AS
    Nature; 1999 Oct; 401(6756):874-5. PubMed ID: 10553903
    [No Abstract]   [Full Text] [Related]  

  • 24. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV chemotherapy.
    Richman DD
    Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent reservoirs of HIV infection: flushing with IL-2?
    Cooper DA; Emery S
    Nat Med; 1999 Jun; 5(6):611-2. PubMed ID: 10371491
    [No Abstract]   [Full Text] [Related]  

  • 30. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 31. [HIV-infection: modern antiretroviral therapy].
    Rockstroh JK; Spengler U
    Dtsch Med Wochenschr; 2004 Sep; 129(37):1921-4. PubMed ID: 15372371
    [No Abstract]   [Full Text] [Related]  

  • 32. [Without pharmacology nearly nothing can be accomplished in HIV medicine. Anti-HIV drugs: on the way to the IQ test!].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():101-2. PubMed ID: 11373759
    [No Abstract]   [Full Text] [Related]  

  • 33. Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
    Grant P; Taylor J; Cain P; Short W; Gallant J; Farthing C; Thal G; Coakley E; Zolopa A
    Clin Infect Dis; 2009 Mar; 48(5):680-2. PubMed ID: 19191657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-HIV drugs work rapidly or not at all. Virus dynamics--therapeutic consequences].
    Aulehla S
    Fortschr Med; 1995 Apr; 113(12):14-6. PubMed ID: 7789929
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV suppression and risk of drug resistance mutations.
    Phillips AN; Loveday C; Johnson MA
    AIDS; 1998 Oct; 12(14):1930. PubMed ID: 9792396
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV survives drug onslaught by hiding out in T cells.
    Balter M
    Science; 1997 Nov; 278(5341):1227. PubMed ID: 9411749
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV/AIDS research. Tissue says blood is misleading, confusing HIV cure efforts.
    Cohen J
    Science; 2011 Dec; 334(6063):1614. PubMed ID: 22194536
    [No Abstract]   [Full Text] [Related]  

  • 39. [AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment].
    Notermans DW; Danner SA; de Wolf F; Lange JM
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1909-12. PubMed ID: 9856176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.
    Chun TW; Engel D; Mizell SB; Hallahan CW; Fischette M; Park S; Davey RT; Dybul M; Kovacs JA; Metcalf JA; Mican JM; Berrey MM; Corey L; Lane HC; Fauci AS
    Nat Med; 1999 Jun; 5(6):651-5. PubMed ID: 10371503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.